320 related articles for article (PubMed ID: 28282997)
21. Testosterone replacement therapy and the risk of prostate cancer.
Warburton D; Hobaugh C; Wang G; Lin H; Wang R
Asian J Androl; 2015; 17(6):878-81; discussion 880. PubMed ID: 25865848
[TBL] [Abstract][Full Text] [Related]
22. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
[TBL] [Abstract][Full Text] [Related]
23. Testosterone Replacement Therapy in Hypogonadal Men Following Prostate Cancer Treatment: A Questionnaire-Based Retrospective Study among Urologists in Bavaria, Germany.
Kühn CM; Strasser H; Romming A; Wullich B; Goebell PJ
Urol Int; 2015; 95(2):153-9. PubMed ID: 25677365
[TBL] [Abstract][Full Text] [Related]
24. Androgen replacement in men undergoing treatment for prostate cancer.
Rhoden EL; Averbeck MA; Teloken PE
J Sex Med; 2008 Sep; 5(9):2202-8. PubMed ID: 18638000
[TBL] [Abstract][Full Text] [Related]
25. Testosterone treatment in hypogonadal men: prostate-specific antigen level and risk of prostate cancer.
Guay AT; Perez JB; Fitaihi WA; Vereb M
Endocr Pract; 2000; 6(2):132-8. PubMed ID: 11421528
[TBL] [Abstract][Full Text] [Related]
26. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
27. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
28. Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry.
Morales A
BJU Int; 2011 May; 107(9):1369-73. PubMed ID: 21518230
[TBL] [Abstract][Full Text] [Related]
29. Effects of androgen deficiency and replacement on prostate zonal volumes.
Jin B; Conway AJ; Handelsman DJ
Clin Endocrinol (Oxf); 2001 Apr; 54(4):437-45. PubMed ID: 11318778
[TBL] [Abstract][Full Text] [Related]
30. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
31. Serum inhibin--not a cause of low testosterone levels in hypogonadal prostate cancer?
Lackner JE; Maerk I; Koller A; Bieglmayer C; Marberger M; Kratzik C; Schatzl G
Urology; 2008 Nov; 72(5):1121-4. PubMed ID: 18407338
[TBL] [Abstract][Full Text] [Related]
32. Is testosterone treatment good for the prostate? Study of safety during long-term treatment.
Feneley MR; Carruthers M
J Sex Med; 2012 Aug; 9(8):2138-49. PubMed ID: 22672563
[TBL] [Abstract][Full Text] [Related]
33. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer.
Pastuszak AW; Khanna A; Badhiwala N; Morgentaler A; Hult M; Conners WP; Sarosdy MF; Yang C; Carrion R; Lipshultz LI; Khera M
J Urol; 2015 Nov; 194(5):1271-6. PubMed ID: 26025500
[TBL] [Abstract][Full Text] [Related]
34. Testosterone therapy and prostate carcinoma.
Rhoden EL; Averbeck MA
Curr Urol Rep; 2009 Nov; 10(6):453-9. PubMed ID: 19863857
[TBL] [Abstract][Full Text] [Related]
35. Testosterone replacement therapy after primary treatment for prostate cancer.
Agarwal PK; Oefelein MG
J Urol; 2005 Feb; 173(2):533-6. PubMed ID: 15643240
[TBL] [Abstract][Full Text] [Related]
36. Testosterone therapy for men at risk for or with history of prostate cancer.
Morgentaler A
Curr Treat Options Oncol; 2006 Sep; 7(5):363-9. PubMed ID: 16904053
[TBL] [Abstract][Full Text] [Related]
37. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls.
Behre HM; Bohmeyer J; Nieschlag E
Clin Endocrinol (Oxf); 1994 Mar; 40(3):341-9. PubMed ID: 7514512
[TBL] [Abstract][Full Text] [Related]
38. Greater percent-free testosterone is associated with high-grade prostate cancer in men undergoing prostate biopsy.
Albisinni S; De Nunzio C; Tubaro A; Barry WT; Banez LL; Freedland SJ
Urology; 2012 Jul; 80(1):162-7. PubMed ID: 22608797
[TBL] [Abstract][Full Text] [Related]
39. Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men.
Rosen RC; Wu FC; Behre HM; Roehrborn CG; Schröder FH; Siami FS; Martha JF; Finn JD; Araujo AB
Aging Male; 2013 Mar; 16(1):1-7. PubMed ID: 23373674
[TBL] [Abstract][Full Text] [Related]
40. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy.
Pastuszak AW; Pearlman AM; Lai WS; Godoy G; Sathyamoorthy K; Liu JS; Miles BJ; Lipshultz LI; Khera M
J Urol; 2013 Aug; 190(2):639-44. PubMed ID: 23395803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]